Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. CHYM
3. BRZE
4. USO
5. KFY
6. EVMN
7. NOVN:SW
8. USB
9. DYN
10. NVS

Go back to Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
MACROGENICS (NASDAQ: MGNX) Delayed: 4.32 --0 (-0%)
Previous Close $4.32    52 Week High $36.11 
Open $4.32    52 Week Low $14.84 
Day High $4.32    P/E 11.08 
Day Low $4.32    EPS $0.39 
Volume 333       

(NASDAQ: ZLAB) Delayed: 25.41 --0 (-0%)
Previous Close $25.41    52 Week High $ 
Open $25.41    52 Week Low $ 
Day High $25.41    P/E N/A 
Day Low $25.41    EPS $ 
Volume 3,467